TWOCELLS Company, Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TWOCELLS Company, Limited - overview
Established
2003
Location
Hiroshima, Hiroshima, Japan
Primary Industry
Biotechnology
About
Founded in 2003 and based in Hiroshima, Japan, TWOCELLS Company, Limited, is a bio-venture company specializing in research, development, and manufacturing of regenerative medicine and automatic cell culturing systems. In July 2024, Hiroshima Innovation Network acquired TWOCELLS Company, Limited. The firm as of August 2024, is led by its President and CEO, Masaya Matsumoto. Two Cells primarily focuses on mesenchymal stem cells (MSCs), which are utilized in developing advanced regenerative therapies.
The company is engaged in the research, development, and commercialization of regenerative medicine products, including the serum-free culture media STK® series, and automated stem cell culturing systems. Two Cells also offers pharmaceuticals, diagnostic agents, and medical devices. Its flagship product, gMSC®1, is a regenerative therapy aimed at knee cartilage repair, although its Phase III clinical trials have faced challenges. The July 2024, acquisition aims to support growth in regenerative medicine and regional economic development.
Current Investors
Hiroshima Innovation Network, Shinsei Capital Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare IT, Diagnostic Equipment, Medical Equipment Distributors, Pharmaceutical Research & Development
Website
www.twocells.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
TWOCELLS Company, Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | TWOCELLS Company, Limited | - | ||||||||
| Buyout | Completed | TWOCELLS Company, Limited | - | ||||||||
| Buyout | Completed | TWOCELLS Company, Limited | - | ||||||||
| Buyout | Completed | TWOCELLS Company, Limited | - | ||||||||
| Buyout | Completed | TWOCELLS Company, Limited | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.